AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Tele-Pulmonary Rehabilitation For Patients With Chronic Lung Diseases

RecruitingNAAges 18 Years - anyAllTel-Aviv Sourasky Medical Center
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Pulmonary rehabilitation is a key treatment for lung diseases, but many patients struggle to attend sessions due to travel distances, physical limitations, or logistical barriers. The purpose of this study is to evaluate whether a tele-pulmonary rehabilitation (TPR) program can improve the rates of treatment initiation and adherence among patients with chronic lung diseases compared to traditional, center-based pulmonary rehabilitation. Additionally, the study will assess improvements in quality of life, physical symptoms, and safety in both groups. This study will enroll 90 patients from two medical centers in Israel (Tel Aviv and Barzilai). Participants will be randomly assigned to one of two groups: 1. The control group will receive usual care with a referral by a pulmonologist to standard pulmonary rehabilitation at a medical center. 2. The intervention group will participate in a

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Patients meeting the Israeli Health Basket criteria for reimbursement of pulmonary rehabilitation (PR), including one of the following conditions: * COPD with an FEV1 below 50% or with severe exacerbation (hospitalization) in the previous year or two moderate exacerbations in the previous year. * Interstitial lung disease with an FVC below 80% or a DLCO below 60%. * Bronchiectasis with at least two exacerbations in the past year or at least one hospitalization, and an FEV1 below 80%. * Pulmonary arterial hypertension. 2. Willingness to initiate a PR or Tele-PR (TPR) programs. 3. Ability to perform the TPR program or traditional PR activities as assessed by a member of the study team prior to enrollment. 4. Agree to participate, with signed informed consent. Exclusion Criteria: 1. Uncontrolled comorbidity (e.g uncontrolled congestive heart failure) 2. Inability to operate the mobile application. 3. Without a mobile device or computer. 4. A hospitalization in the 2-months prior to randomization. 5. Completed PR program in the last 12 months. 6. Inability to complete 10 repetitions in the 1-minute sit-to-stand test or 5-second single-leg stance 7. Pregnancy 8. Inability to provide informed consent due to impaired decision-making capacity, as determined by the study's capacity assessment.
๐Ÿ’Š

What it tests

  • Tele-Rehabilitation
๐Ÿ“

Where

2 sites
Barzilai Medical Center
Ashkelon, Israel
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy